Related content

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative study of polymorphism frequencies of the CYP2D6, CYP3A5, CYP2C8 and IL-10 genes in Mexican and Spanish women with breast cancer

By Alcazar-González Gregorio Antonio   Calderón-Garcidueñas Ana Laura   Garza-Rodríguez María Lourdes   Rubio-Hernández Gabriela   Escorza-Treviño Sergio   Olano-Martin Estibaliz   Cerda-Flores Ricardo Martín   Castruita-Avila Ana Lilia   González-Guerrero Juan Francisco   le Brun Stéphane   Simon-Buela Laureano   Barrera-Saldaña Hugo Alberto  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1583-1592

Future Medicine

Access to resources Recommend Favorite

Implementation of CYP2D6 genotyping in psychiatry

By Loovers Harriët M   van der Weide Jan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6 and the severity of suicide attempts

By Peñas-Lledó Eva M   Blasco-Fontecilla Hilario   Dorado Pedro   Vaquero-Lorenzo Concepción   Baca-García Enrique   Llerena Adrián  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 179-184

Future Medicine

Access to resources Recommend Favorite

Molecular Characterization of CYP2B6 Substrates

By  

Current Drug Metabolism, Vol. 9, Iss. 5, 2008-06 ,pp. : 363-373

Bentham Science Publishers

Access to resources Recommend Favorite